{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T01:25:54Z","timestamp":1786670754147,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004434","name":"University of Florence","doi-asserted-by":"publisher","award":["B55F21007810001"],"award-info":[{"award-number":["B55F21007810001"]}],"id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["1R01AI153264"],"award-info":[{"award-number":["1R01AI153264"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejmech.2025.117620","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T19:03:52Z","timestamp":1744398232000},"page":"117620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Redesigning oxazolidinones as carbonic anhydrase inhibitors against vancomycin-resistant enterococci"],"prefix":"10.1016","volume":"291","author":[{"given":"Andrea","family":"Ammara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Giovannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader S.","family":"Abutaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Abouelkhair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemente","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Gratteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-702X","authenticated-orcid":false,"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117620_bib1","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1021\/acs.jmedchem.1c00480","article-title":"Current landscape and future perspective of oxazolidinone scaffolds containing antibacterial drugs","volume":"64","author":"Zhao","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib2","first-page":"188","article-title":"The discovery of linezolid, the first oxazolidinone antibacterial agent","volume":"1","author":"Ford","year":"2001","journal-title":"Curr. Drug Targets: Infect. Disord."},{"key":"10.1016\/j.ejmech.2025.117620_bib3","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/anie.200200528","article-title":"Oxazolidinone structure-activity relationships leading to linezolid","volume":"42","author":"Barbachyn","year":"2003","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117620_bib4","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/AAC.42.12.3251","article-title":"The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria","volume":"42","author":"Swaney","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117620_bib5","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0163-4453(09)60009-8","article-title":"A review of safety and tolerability","volume":"59","author":"Vinh","year":"2009","journal-title":"J. Infect."},{"key":"10.1016\/j.ejmech.2025.117620_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-015-0060-3","article-title":"Tedizolid phosphate: a next-generation oxazolidinone","volume":"4","author":"Rybak","year":"2015","journal-title":"J. Infect. Dis. Ther."},{"key":"10.1016\/j.ejmech.2025.117620_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2146\/ajhp130482","article-title":"A new oxazolidinone antimicrobial","volume":"71","author":"Kisgen","year":"2014","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ejmech.2025.117620_bib8","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1128\/AAC.00458-12","article-title":"In vitro activity and microbiological efficacy of tedizolid (TR-700) against gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections","volume":"56","author":"Prokocimer","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117620_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7547\/15-218","article-title":"Tedizolid and linezolid for treatment of acute bacterial skin and skin structure infections of the lower extremity versus non-lower-extremity infections: pooled analysis of two phase 3 trials","volume":"107","author":"Joseph","year":"2017","journal-title":"J. Am. Podiatr. Med. Assoc."},{"key":"10.1016\/j.ejmech.2025.117620_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/antibiotics10070755","article-title":"Pharmacokinetic\/Pharmacodynamic analysis of tedizolid phosphate compared to linezolid for the treatment of infections caused by gram-positive bacteria","volume":"10","author":"Rodr\u00edguez-Gasc\u00f3n","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2025.117620_bib11","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1128\/AAC.00274-13","article-title":"Activity of tedizolid (TR-700) against well-characterized methicillin-resistant Staphylococcus aureus strains of diverse epidemiological origins","volume":"57","author":"Thomson","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117620_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/jac\/dkv302","article-title":"Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin, or linezolid","volume":"71","author":"Barber","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.117620_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/microbiolspec.GPP3-0053-2018","article-title":"Pathogenicity of enterococci","volume":"7","author":"Fiore","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2025.117620_bib14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1089\/mdr.2017.0147","article-title":"Vancomycin-resistant enterococci: a review of antimicrobial resistance mechanisms and perspectives of human and animal health","volume":"24","author":"Ahmed","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.ejmech.2025.117620_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/cid\/ciy903","article-title":"Linezolid- and vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: infection control and antimicrobial stewardship using whole genome sequencing","volume":"69","author":"Abbo","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117620_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/civ444","article-title":"Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of veterans affairs patients","volume":"61","author":"Britt","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117620_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02216-16","article-title":"Effect of continuous and sequential therapy among veterans receiving daptomycin or linezolid for vancomycin-resistant Enterococcus faecium bacteremia","volume":"61","author":"Britt","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117620_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/CE.S33430","article-title":"An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy","volume":"7","author":"Watkins","year":"2012","journal-title":"Core Evid."},{"key":"10.1016\/j.ejmech.2025.117620_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/432121","article-title":"Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection","volume":"41","author":"Munoz-Price","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117620_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tim.2017.01.004","article-title":"Multidrug-resistant enterococcal infections: new compounds, novel antimicrobial therapies?","volume":"25","author":"van Harten","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2025.117620_bib21","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ofid\/ofw172.1047","article-title":"Tedizolid for treatment of enterococcal bacteremia","volume":"3","author":"Sudhindra","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117620_bib22","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1080\/14756366.2022.2092729","article-title":"Structure-activity relationship studies for inhibitors for vancomycin-resistant enterococcus and human carbonic anhydrases","volume":"37","author":"An","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/acsmedchemlett.3c00032","article-title":"Evaluation of 1,3,4-Thiadiazole carbonic anhydrase inhibitors for gut decolonization of vancomycin-resistant enterococci","volume":"14","author":"Abutaleb","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117620_bib24","doi-asserted-by":"crossref","first-page":"e01715","DOI":"10.1128\/AAC.01715-20","article-title":"In vivo antibacterial activity of acetazolamide","volume":"65","author":"Abutaleb","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117620_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/antibiotics12010142","article-title":"Carbonic anhydrase inhibitors as novel antibacterials in the era of antibiotic resistance: where are we now?","volume":"12","author":"Nocentini","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2025.117620_bib26","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.4155\/fmc-2021-0207","article-title":"Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets","volume":"13","author":"Flaherty","year":"2021","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib27","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/pathogens10101310","article-title":"Bacterial antibiotic resistance: the Most critical pathogens","volume":"10","author":"Mancuso","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2025.117620_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108550","article-title":"Multitarget antibacterial drugs: an effective strategy to combat bacterial resistance","volume":"252","author":"Feng","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.117620_bib29","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1021\/acs.jmedchem.4c00740","article-title":"Development of penicillin-based carbonic anhydrase inhibitors targeting multidrug-resistant Neisseria gonorrhoeae","volume":"67","author":"Bonardi","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib30","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1021\/acs.jmedchem.4c01555","article-title":"Inhibition of Pseudomonas aeruginosa carbonic anhydrases: exploring ciprofloxacin functionalization toward new antibacterial agents: an In-Depth multidisciplinary study","volume":"67","author":"Marinacci","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib31","doi-asserted-by":"crossref","first-page":"13860","DOI":"10.1021\/acs.jmedchem.3c01040","article-title":"Strategies for the discovery of oxazolidinone antibacterial agents: development and future perspectives","volume":"66","author":"Liu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116397","article-title":"Synthesis, microbiological evaluation, and structure-activity relationship analysis of linezolid analogues with different C5-Acylamino substituents","volume":"49","author":"Matsingos","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib33","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1039\/D2MD00415A","article-title":"Oxazolidinones as versatile scaffolds in medicinal chemistry","volume":"14","author":"Fernandes","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib34","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/jm800379d","article-title":"Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit","volume":"51","author":"Ippolito","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41594-022-00723-9","article-title":"Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics","volume":"29","author":"Tsai","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117620_bib36","doi-asserted-by":"crossref","first-page":"E5805","DOI":"10.1073\/pnas.1517952112","article-title":"Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus","volume":"112","author":"Eyal","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2025.117620_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/acsptsci.0c00041","article-title":"Characterization of the core ribosomal binding region for the oxazolidone family of antibiotics using Cryo-EM","volume":"3","author":"Wright","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejmech.2025.117620_bib38","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1128\/AAC.00419-12","article-title":"Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis","volume":"56","author":"Diaz","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117620_bib39","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1016\/j.bmcl.2017.10.018","article-title":"Compounds design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: test case for a general approach to improving whole cell gram-negative activity","volume":"27","author":"Spaulding","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117620_bib40","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73199-6","article-title":"Cryo-electron microscopy structure of the 70S ribosome from Enterococcus faecalis","volume":"10","author":"Murphy","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117620_bib42","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically","year":"2012"},{"key":"10.1016\/j.ejmech.2025.117620_bib43","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1107\/S1744309109036665","article-title":"High-resolution structure of human carbonic anhydrase II complexed with acetazolamide reveals insights into inhibitor drug design","volume":"65","author":"Sippel","year":"2009","journal-title":"Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.ejmech.2025.117620_bib44","article-title":"Antiviral activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies","volume":"55","author":"Sayed","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2025.117620_bib45","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.1021\/acs.jmedchem.0c00734","article-title":"Optimization of acetazolamide-based scaffold as potent inhibitors of vancomycin-resistant enterococcus","volume":"63","author":"Kaur","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.009","article-title":"Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies","volume":"55","author":"Abutaleb","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2025.117620_bib47","first-page":"D523","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117620_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168022","article-title":"High-resolution crystal structure of a psychrohalophilic \u03b1-Carbonic anhydrase from Photobacterium profundum reveals a unique dimer interface","volume":"11","author":"Somalinga","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.117620_bib49","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1107\/S0907444912017210","article-title":"J.H.Structures \u03b3-Class carbonic anhydrase homologue YrdA suggest possible allosteric switch","volume":"68","author":"Park","year":"2012","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2025.117620_bib50","series-title":"Schr\u00f6dinger Suite Release 2024-3","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117620_bib51","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117620_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117620_bib53","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2025.117620_bib54","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera \u2013 a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41442-5","article-title":"Substituted salicylic acid analogs offer improved potency against multidrug-resistant Neisseria gonorrhoeae and good selectivity against commensal vaginal bacteria","volume":"13","author":"Almolhim","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117620_bib56","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1039\/D3RA07619A","article-title":"Novel phenylthiazoles with a tert-butyl moiety: promising antimicrobial activity against multidrug-resistant pathogens with enhanced ADME properties","volume":"14","author":"Hagras","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117620_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115789","article-title":"Discovery of 1,2-Diaryl-3-Oxopyrazolidin-4-Carboxamides as a new class of MurA enzyme inhibitors and characterization of their antibacterial activity","volume":"261","author":"Wagdy","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib58","article-title":"SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against gram-negative bacteria","volume":"247","author":"E","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117620_bib59","doi-asserted-by":"crossref","first-page":"15537","DOI":"10.1021\/acs.jmedchem.4c01187","article-title":"Optimization of ethoxzolamide analogs with improved pharmacokinetic properties for in vivo efficacy against Neisseria gonorrhoeae","volume":"67","author":"Youse","year":"2024","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500385X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500385X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:46:04Z","timestamp":1778042764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342500385X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":59,"alternative-id":["S022352342500385X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117620","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redesigning oxazolidinones as carbonic anhydrase inhibitors against vancomycin-resistant enterococci","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117620"}}